Skip to main content

What the FDA labels say about taking them together

Dihydroergotamine and midodrine

Midodrine's FDA label of December 4, 2025 names dihydroergotamine in its drug interactions section; the dihydroergotamine labels PlainMeds reads (4) do not name midodrine. The midodrine label: “The risk of hypertension increases with concomitant administration of drugs that increase blood pressure.”

Check it at the source: the dihydroergotamine FDA label on DailyMed (effective March 6, 2025, Oceanside Pharmaceuticals); the midodrine FDA label on DailyMed (effective December 4, 2025, Novugen Pharma (USA) LLC).

What does the dihydroergotamine label say about midodrine?

Dihydroergotamine's label (effective March 6, 2025) and its 3 other brand-application labels do not name midodrine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Dihydroergotamine Mesylate), NDA020148 (Bausch), as published by Oceanside Pharmaceuticals, effective March 6, 2025 (SPL set 977de209-c53a-4cb4-9f3f-1e850600a9dc), via openFDA; the full label on DailyMed

What does the midodrine label say about dihydroergotamine?

Midodrine label, drug interactions

The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa).

Source: FDA drug label (Midodrine Hydrochloride), Novugen Pharma (USA) LLC, effective December 4, 2025 (SPL set 2bf011fe-d114-42a4-93e2-76a993a3ba34), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Dihydroergotamine generic labelers
33Midodrine generic labelers
DihydroergotamineMidodrine
Labeled forMigrainen/a
Boxed warningYesYes
Pharmacy cost (NADAC)$29.44 per mL 4 mg/mL nasal spray$0.111 per tablet 5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?